Patient preference for cancer therapy: an overview of measurement approaches.
about
Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experienceAnticipated adaptation or scale recalibration?A regret theory approach to decision curve analysis: a novel method for eliciting decision makers' preferences and decision-making.Women's preference for laparoscopic or abdominal hysterectomyShared decision-making in the primary care treatment of late-life major depression: a needed new intervention?Training recruiters to randomized trials to facilitate recruitment and informed consent by exploring patients' treatment preferencesAsthma control cost-utility randomized trial evaluation (ACCURATE): the goals of asthma treatment.Patient-reported outcomes and survivorship in radiation oncology: overcoming the consAssessment of patient-reported outcomes in patients with melanoma.Patient preferences for side effects associated with cervical cancer treatmentEthical issues in autologous stem cell transplantation (ASCT) in advanced breast cancer: a systematic literature review.Determining whether a patient is feeling better: pitfalls from the science of human perception.Exploring treatment preferences facilitated recruitment to randomized controlled trials.Noncompliance to guidelines in head and neck cancer treatment; associated factors for both patient and physician.Shared decision making in oncology practice: what do oncologists need to know?Chemotherapy use and patient treatment preferences in advanced colorectal cancer: a prospective cohort studyPalliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice.Adjuvant chemotherapy for colorectal cancer: age differences in factors influencing patients' treatment decisions.Health-state utilities in liver disease: a systematic review.Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG study.Why values elicitation techniques enable people to make informed decisions about cancer trial participation.Measuring outcomes in oncology treatment: the importance of patient-centered outcomesIntraoperative radiotherapy for early breast cancer: do health professionals choose convenience or risk?Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist).Introductory insights into patient preferences for outpatient rehabilitation after knee replacement: implications for practice and future research.Offering chemotherapy and hospice jointly: one solution to hospice underuse.Quality of life: a deconstruction for clinicians.
P2860
Q24792539-E32447E0-DD5F-4513-B6C8-A7B02B85F8FDQ33592733-EC0CDC09-9F3C-4932-9EC4-687B63F28833Q33693923-E2B78BCF-CDBB-4D45-8312-4C46EB515C25Q33722334-4089CFA4-FFFE-400C-8FA7-04C3981AF048Q33927730-EE1B2355-A1CF-4A35-8955-6F5F213FBDD7Q34067540-FFE2D098-516B-4D40-8499-B9629F2AD46DQ34083048-4AC60AC2-3510-41C6-A816-8C8092C525A2Q34124311-40790DC1-F571-448B-A80E-4E941F60F662Q34371938-E93F0802-A2F8-48A9-9D3D-218F9CF2D542Q34871388-FB07313A-7A6B-44FC-B67B-0206DD7512ECQ35011451-FEAC2F4B-3AC1-4DF7-9EEA-CAA6318049F8Q35113148-07B6D25A-2566-4594-9304-7F75F55695ECQ35197425-1BE953FC-CB65-4C5B-A8C3-DE247D92CD2FQ35688559-BDB3D321-3D02-40FC-A3EC-484F0225B6FDQ35705334-1212F445-21D8-46AF-B59E-5C5E2055837FQ36542468-0F51D2F4-1E8A-4E35-84A7-2FC84C043599Q36673526-A4F4169E-2498-43A3-9F49-1E69121BD966Q37128095-73CB2BB0-5945-400D-B68D-F3A871E7AC08Q37142994-DAD43A2D-9D23-4FB4-BA49-DE6E259820F0Q37249312-FE1443B4-42AD-43BC-9ED3-05464E6141F4Q37325532-F51327F4-C3A9-4436-8B12-1B2E5F7F0256Q37383022-8BABC5B2-2AEE-46B9-8610-120D5A932335Q37533221-00B96590-F3B7-4B4F-9803-8A940BCB8C6DQ39001743-2A8DBFF3-46DB-4AB7-BFB8-7AF77B3563B4Q39794812-A35702A8-7C17-49AE-B525-708E6B8597E8Q46914008-EF2C0135-6D29-455E-B0A0-9827C2D06AD5Q53414380-5D8776C9-2B29-43D4-87C1-11B75BF96FF8
P2860
Patient preference for cancer therapy: an overview of measurement approaches.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Patient preference for cancer therapy: an overview of measurement approaches.
@ast
Patient preference for cancer therapy: an overview of measurement approaches.
@en
Patient preference for cancer therapy: an overview of measurement approaches.
@nl
type
label
Patient preference for cancer therapy: an overview of measurement approaches.
@ast
Patient preference for cancer therapy: an overview of measurement approaches.
@en
Patient preference for cancer therapy: an overview of measurement approaches.
@nl
prefLabel
Patient preference for cancer therapy: an overview of measurement approaches.
@ast
Patient preference for cancer therapy: an overview of measurement approaches.
@en
Patient preference for cancer therapy: an overview of measurement approaches.
@nl
P1476
Patient preference for cancer therapy: an overview of measurement approaches
@en
P2093
J C de Haes
P304
P356
10.1200/JCO.2001.19.1.220
P407
P577
2001-01-01T00:00:00Z